Navigation Links
Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation
Date:11/11/2008

darone showed a low risk of pro-arrhythmia and no excess of hospitalizations for congestive heart failure. There was a similar rate of study drug discontinuation between the 2 study groups.

About Atrial Fibrillation

Atrial fibrillation (AF) is a common heart arrhythmia in which the upper chambers of the heart beat in an uncoordinated and disorganised fashion, which can cause palpitations, shortness of breath and fatigue. Atrial fibrillation (AF) currently represents a major economic burden for society(3). 70 percent of the annual cost of AF management is driven by inpatient care and interventional procedures(4). Hospitalizations for AF have increased dramatically (2- to 3-fold) in recent years(5). AF hospitalizations now represent a third of all hospitalizations for arrhythmia and mortality. AF affects nearly seven million people in the European Union and the United States(6).

The condition is increasingly frequent with advancing age and is often caused by age-related changes in the heart or as a result of cardiovascular disease. AF increases the risk of stroke five-fold and heart failure two- to three-fold. AF also doubles the risk of mortality and is an independent risk factor for sudden cardiac death.

Without appropriate management, AF can lead to serious complications such as stroke and congestive heart failure. In addition to preventing stroke and reducing the burden of the disease, successful management of AF should also aim at further reducing CV morbidity and mortality(7).

The aims of treatment for patients with AF are related to managing the arrhythmia itself and to the prevention of thromboembolism (obstruction of a blood vessel caused by fragments of a blood clot carried from the site of origin to obstruct another vessel). Atrial fibrillation may be treated with medications which either slow the heart rate or revert the heart rhythm back to normal.

About the ATHENA Study

The landmark ATHENA study is the onl
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
2. ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
3. ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
4. Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation
5. American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation
6. Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
7. Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
8. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
9. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
10. Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
11. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015 Hill-Rom,s recent ... $2 billion in cash and stock means the ... market, according to Kalorama Information. The healthcare market ... the medical device and advanced wound care markets, ... beds, patient lifting devices, and other healthcare equipment. ...
(Date:7/7/2015)... July 7, 2015 According ... "Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - ... I-131, Alpha Emitters, Brachytherapy - Y-90), by Application ... published by MarketsandMarkets, this report studies the global ... 2015 to 2020. This market is expected to ...
(Date:7/7/2015)... -- A power morcellator lawsuit ( http://www.morcellatorlawsuit2015.com ) filed ... undisclosed amount, Bernstein Liebhard LLP reports. According to court ... the U.S. District Court, Eastern District of ... wife had died in February 2013, just 11 months ... use of a power morcellator. Following the surgery, it ...
Breaking Medicine Technology:Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 2Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 2Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 4Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 2Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 3
... Varian Medical Systems (NYSE: VAR ) is ... at 9:30 a.m. ET on Wednesday, November 17th at ... Participating executives will include Elisha Finney, senior vice ... investor relations and corporate communications. The presentation will focus ...
... GREENSBORO, N.C., Nov. 5, 2010 Merz Pharmaceuticals announced ... Xeomin® (incobotulinumtoxinA), a botulinum toxin type A free from ... Assembly of the American Academy of Physical Medicine and ... U.S. Food and Drug Administration (FDA) approved XEOMIN on ...
Cached Medicine Technology:Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 2Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 3Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 4Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 5Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 6
(Date:7/7/2015)... ... July 07, 2015 , ... ... the two firms have merged to form Camber Collective. Camber Collective provides ... The merger combines SwitchPoint’s strategy consulting expertise with Hope Consulting’s deep experience ...
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois cannabis cultivation ... limited to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) board and ... and are committed to making sure patients have access to cannabis as a ...
(Date:7/7/2015)... ... July 07, 2015 , ... Summer is a great time ... so Amica Insurance is sharing some safety tips. , Jean Tapley, senior wellness coordinator ... Leisure activities/sports, , Start slowly. Going from no activity to ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... Downtown Detroit was the site of the National Baptist Convention 110th Annual Session ... on encouraging and promoting the collaboration of churches and their congregations, medical professionals ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... relations, marketing, and creative design firm, today announced that TimberNook ( http://www.timbernook.com/ ... and social media campaign, content strategy, and marketing launch package for new ...
Breaking Medicine News(10 mins):Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2
... for ... Secure Remote Access, ... non-profit hospital system, has chosen PowerTerm WebConnect,Ericom Software,s alternative to ... with secure, on-demand remote access to medical,applications and confidential patient ...
... York, N.Y. (Sept. 25, 2007) The majority of breast ... according to new survey results released today. However, the ... take to lessen the likelihood of recurrence is surprisingly ... AstraZeneca and conducted by Harris Interactive, consisted of interviews ...
... and Secure Data, Replication for United Mine Workers ... PRAIRIE, Minn., Sept. 25 Xiotech Corporation today,announced ... Health and,Retirement Funds has activated Xiotech(R) TimeScale(TM) Replication,Services ... recovery plan. The,hosted service is protecting the health ...
... YORK, Sept. 25 MS sufferers, who have found ... diet that targets,five food triggers. Sugar and saturated fats ... food sensitivities, along with,other simple dietary changes, the MS ... with MS. "By not activating the immune system, ...
... new song has helped scientists open a new avenue of ... there is currently no cure or even a treatment to ... in the Journal of Clinical Investigation, scientists at the University ... someday be used to treat the disease. The team used ...
... in the Wadden Sea so you have to search for it. ... the best place to go? Initially the food rich spots always ... other animals of course and that gives rise to food competition. ... the prey caught. , Takeaway meal , Experiments revealed ...
Cached Medicine News:Health News:Ericom Provides Significant Cost-Savings for Major New York City Healthcare Organization 2Health News:Breast cancer survivors optimistic, yet lack critical information on reducing recurrence 2Health News:Health and Pension Benefits Provider Turns to Xiotech's TimeScale Replication Services to Protect Critical Data 2Health News:Health and Pension Benefits Provider Turns to Xiotech's TimeScale Replication Services to Protect Critical Data 3Health News:Multiple Sclerosis Patients Find Dietary Treatment More Effective Than Pharmaceutical Regimens 2Health News:Stem cells show promise for treating Huntington's disease 2Health News:Stem cells show promise for treating Huntington's disease 3Health News:Stem cells show promise for treating Huntington's disease 4
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: